We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

4 hedge funds and large institutions have $6.25M invested in Plus Therapeutics in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $80K | Put options by funds: $62K

20% less funds holding

Funds holding: 5 → 4 (-1)

21% less capital invested

Capital invested by funds: $7.87M → $6.25M (-$1.62M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
$80K
Puts
$62K
Net Calls
+$18K
Net Calls Change
+$29K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$1.22M
2
SM
Sabby Management
Florida
-$388K
3
SIM
Spark Investment Management
New York
-$44K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$26K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$3.58M -$388K -1 -10%
PCM
2
Perkins Capital Management
Minnesota
$790K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$672K – – –
BIT
4
BlackRock Institutional Trust
California
$514K – – –
Creative Planning
5
Creative Planning
Kansas
$158K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$122K – – –
VKH
7
Virtu KCG Holdings
New York
$78K – – –
BFA
8
BlackRock Fund Advisors
California
$68K – – –
PCMI
9
Princeton Capital Management Inc
New Jersey
$58K – – –
Northern Trust
10
Northern Trust
Illinois
$35K – – –
Wolverine Trading
11
Wolverine Trading
Illinois
$34K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$28K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$27K – – –
Simplex Trading
14
Simplex Trading
Illinois
$26K – – –
UB
15
UMB Bank
Missouri
$25K – – –
AIM
16
Acrospire Investment Management
Illinois
$7K – – –
BIM
17
BlackRock Investment Management
Delaware
$7K – – –
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$6K – – –
BA
19
BlackRock Advisors
Delaware
$5K – – –
Barclays
20
Barclays
United Kingdom
$3K – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$2K – – –
UBS Group
22
UBS Group
Switzerland
$2K – – –
KLI
23
Kelman-Lazarov Inc
Tennessee
$1.59K – – –
Bank of America
24
Bank of America
North Carolina
$1K – – –
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
1
2

PSTV Hedge Fund Activity: Q3 2016 in Review

4 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2016, worth a combined $6.25M — down 21% from $7.87M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTV and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Anson Funds Management, exiting entirely with an estimated $1.22M sold.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q3 2016, down from 5 in Q2 2016.
  • Funds reported $6.25M of Plus Therapeutics stock for Q3 2016, down 21% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q3 2016 and 1 closed out, a net change of -1 holder.
  • The largest Plus Therapeutics seller in Q3 2016 was Anson Funds Management, an estimated $1.22M sold.

Based on aggregated 13F filings for Q3 2016.